| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Duchenne/ Becker Muscular Dystrophy
|
NHLBI
|
5R01HL073315-05
|
|
Functional Phenotyping of Cardiomyopathy by MRI
|
YU, XIN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$362,679
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR049899-05
|
|
Costamere Defects in Muscular Dystrophies
|
ERVASTI, JAMES
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$336,457
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1R21AR055725-01
|
|
Use of matrix metalloproteinase to improve myogenic cell transplantation in MDX m
|
LI, YONG
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$179,850
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5K08NS051349-03
|
|
Myoregenerative Potential of ABCB5+ Progenitors
|
FRANK, NATASHA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$133,920
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5K08NS049346-03
|
|
Role of TGF-B1 in Duchenne Muscular Dystrophy
|
ZHOU, LAN
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$169,668
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR053242-03
|
|
Immune Tolerence to Transplanted Myoblasts
|
ROTHSTEIN, DAVID
|
YALE UNIVERSITY
|
CT
|
$290,704
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR050202-05
|
|
Galgt2, dystroglycan, and muscle extracellular matrix
|
MARTIN, PAUL
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$261,259
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R37AR040864-19
|
|
Dystrophin Replacement in mdx mice
|
CHAMBERLAIN, JEFFREY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$504,779
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIDDK
|
1R41DK076516-01A2
|
|
A novel approach for gene therapy
|
MAAS, STEFAN
|
ATIGEN
|
PA
|
$139,916
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR049722-03
|
|
Glycosyltransferase Therapy for Myopathies
|
MARTIN, PAUL
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$297,273
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR044533-13
|
|
Assembly of the Dystrophin-Glycoprotein Complex
|
CHAMBERLAIN, JEFFREY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$328,692
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR042423-14
|
|
Cytoskeletal interactions of Dystrophin
|
ERVASTI, JAMES
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$294,551
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR048871-06
|
|
Regulation of Utrophin Promoter in Muscle
|
KHURANA, TEJVIR
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$286,646
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R21AR055712-02
|
|
Muscle-specific AAV Vectors for DMD Gene Therapy
|
SAMULSKI, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$153,811
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR051034-05
|
|
Ischemia and the Pathogenesis of Muscular Dystrophy
|
THOMAS, GAIL
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$296,801
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
1F31NS056780-01A2
|
|
Inducing Tolerance to Gene Transfer in Dystrophic Mice
|
EGHTESAD, SAMAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$40,972
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR050595-06
|
|
Gene Therapy for a severe DMD Animal Model
|
XIAO, XIAO
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$297,689
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5R01NS043264-06
|
|
Translational Research in the Dystrophinopathies
|
FLANIGAN, KEVIN
|
UNIVERSITY OF UTAH
|
UT
|
$913,423
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R03AR054084-03
|
|
Regulation of Oxidative Stress in the mdx Diaphragm
|
LAWLER, JOHN
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$66,360
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5F32AR053803-03
|
|
Role of PPAR-delta in Duchenne Muscular Dystrophy
|
NARKAR, VIHANG
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
CA
|
$56,702
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R03AR054955-02
|
|
Adult muscle stem cells as cell therapy in utrophin-dystrophin deficient mice
|
REYES, MORAYMA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$81,340
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIGMS
|
1R01GM086167-01
|
|
Intracellular calcium signaling in normal and diseased mammalian skeletal muscle
|
BAYLOR, STEPHEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$315,000
|
|
Duchenne/ Becker Muscular Dystrophy
|
NHLBI
|
5R01HL063134-08
|
|
Physiology of Respiratory Muscle Micromechanics
|
BORIEK, ALADIN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$399,263
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5F31NS058224-02
|
|
Delivery of a Myostatin Inhibitor by AAV Gene Therapy for Muscular Dystrophy
|
HAIDET, AMANDA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$31,003
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR050565-05
|
|
Genetic Rescue of Dystrophic Muscle In Utero
|
CLEMENS, PAULA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$219,858
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIA
|
5R01AG024987-05
|
|
Regulator of Adult Stem Cell Fate
|
BLAU, HELEN
|
STANFORD UNIVERSITY
|
CA
|
$300,216
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R01AR053970-03
|
|
Structure of the dystrophin rod in relation to exon boundaries and exon skipping
|
MENHART, NICK
|
ILLINOIS INSTITUTE OF TECHNOLOGY
|
IL
|
$136,327
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1R01AR053697-01A2
|
|
Integrin Alleviation of Muscular Dystrophy
|
BURKIN, DEAN
|
UNIVERSITY OF NEVADA RENO
|
NV
|
$247,133
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
1R21NS059514-01A1
|
|
cGMP Phosphodiesterase Inhibitors in a Mouse Model of Duchenne Muscular Dystrophy
|
FROEHNER, STANLEY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$204,750
|
|
Duchenne/ Becker Muscular Dystrophy
|
NHLBI
|
1R21HL089684-01A1
|
|
Sonic Muscle Regeneration
|
POLA, ROBERTO
|
CARITAS ST. ELIZABETH'S MEDICAL CENTER
|
MA
|
$212,500
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
2R01AR049419-06
|
|
Dual AAV Vectors for Duchenne Muscular Dystrophy Therapy
|
DUAN, DONGSHENG
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$438,213
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5K08AR052308-04
|
|
Creative biosynthesis mitigates pathogenesis in mdx mice
|
TSENG, BRIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$126,900
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5K02AR051181-05
|
|
Strategies to improve stem cell engraftment into muscle
|
WANG, YAMING
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$106,920
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5R21AR055878-02
|
|
Testing a Novel DMD Therapeutic in MDX Mice
|
FALLON, JUSTIN
|
BROWN UNIVERSITY
|
RI
|
$127,267
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U01NS052476-02
|
|
Translational program for molecular therapeutics in DMD
|
STEDMAN, HANSELL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$983,535
|
|
Duchenne/ Becker Muscular Dystrophy
|
NHLBI
|
5R01HL086790-02
|
|
Chemical-based membrane sealants for dystrophic muscle
|
METZGER, JOSEPH
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$453,020
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5F31AR054724-03
|
|
Immune and muscle cell interactions that modulate dystrophinopathy
|
VILLALTA, SERGIO
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$31,038
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5F32AR054699-02
|
|
A therapeutic approach to muscle wasting by limiting protein breakdown
|
BRAULT, JEFFREY
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$54,842
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5F32AR055008-02
|
|
Dystrophin restoration in two animal models of Duchenne Muscular Dystrophy
|
RODINO, LOUISE
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$49,646
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5F32AR055005-02
|
|
Does catalase expression improve the function muscles from of mdx and LGMD mice?
|
SELSBY, JOSHUA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$12,715
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5R21NS058429-02
|
|
A drug-based approach for integrin-mediated alleviation of muscular dystrophy
|
BURKIN, DEAN
|
UNIVERSITY OF NEVADA RENO
|
NV
|
$215,141
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
1R21NS062934-01
|
|
Expressing full-length dystrophin with AAV
|
DUAN, DONGSHENG
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$163,516
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
1R21NS058926-01A2
|
|
Stakeholders' Views on Research Design: The Duchenne Muscular Dystrophy Community
|
NELSON, ROBERT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$179,922
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1R21AR053901-01A2
|
|
Does sleep apnea exacerbate respiratory muscle dysfunction in muscular dystrophy?
|
FARKAS, GASPAR
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$209,220
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
1R21NS058336-01A2
|
|
Gene Therapy for Muscular Dystrophy
|
CHAO, HENGJUN
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$191,893
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1K99AR054793-01A2
|
|
Calcium Regulation in the Progression of Muscular Dystrophy
|
WEISLEDER, NOAH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
NJ
|
$79,731
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1U54AR056953-01
|
9002
|
National Canine Muscular Dystrophy Core
|
KORNEGAY, JOE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$90,744
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1U54AR056953-01
|
0001
|
Safety and Feasibility Study of Transvenous Limb Perfusion with Normal Saline in
|
POWERS, WILLIAM
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$243,326
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1U54AR056953-01
|
0002
|
Gene therapy in golden retriever muscular dystrophy model
|
XIAO, XIAO
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$349,687
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1U54AR056953-01
|
0003
|
Adeno-associated Virus Vectors for Targeted and Repeat Delivery
|
SAMULSKI, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$337,966
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
1U44NS060181-01A1
|
|
Preclinical Studies Supporting Phase Ib Study of Minidystrophin Gene in AAV Vecto
|
MCPHEE, SCOTT
|
ASKLEPIOS BIOPHARMACEUTICAL, INC.
|
NC
|
$320,998
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1R01AR053933-01A2
|
|
Mitochondria and calcium signaling in skeletal muscle
|
SHIROKOVA, NATALIA
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$330,880
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5P01NS046788-05
|
0001
|
Dystrophin Delivery to Muscle via Myogenic Precursors
|
CHAMBERLAIN, JEFFREY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$610,728
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5P01NS046788-05
|
0003
|
Cell Culture Models for Testing Dystrophobic Muscle Gene Therapy
|
HAUSCHKA, STEPHEN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$272,454
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5P01NS046788-05
|
9001
|
Core--Mouse Biology
|
CHAMBERLAIN, JEFFREY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$84,886
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U54NS053672-04
|
0001
|
Novel therapeutics strategies for Duchenne Muscular Dystrophy
|
CAMPBELL, KEVIN
|
UNIVERSITY OF IOWA
|
IA
|
$306,092
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1R21AR057209-01A1
|
|
Exploring systemic AAV gene delivery in the dystrophic dog
|
DUAN, DONGSHENG
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$175,887
|
|
Duchenne/ Becker Muscular Dystrophy
|
OD
|
3U54HD053177-03S1
|
|
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr
|
HOFFMAN, ERIC
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$6,000
|
|
Duchenne/ Becker Muscular Dystrophy
|
OD
|
2R56AR047664-06
|
|
Excitation-contraction Coupling in Normal and Dystrophic Mammalian Muscle
|
VERGARA, JULIO
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$338,800
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5U54AR052646-04
|
0003
|
Synergistic Effects of IGF-1 and Myostatin Modilation in Muscle
|
WAGNER, KATHRYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$353,366
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5U54AR052646-04
|
0004
|
Clinical Studies of Protease Inhibition in Duchenne Muscular Dystrophy
|
FISCHBECK, KENNETH
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$61,905
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5U54NS058572-02
|
0001
|
Development of Novel Small Molecules for Delaying the Progression of Muscular Dys
|
SWEENEY, HUGH
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$51,019
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U54NS058572-02
|
0001
|
Development of Novel Small Molecules for Delaying the Progression of Muscular Dys
|
SWEENEY, HUGH
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$455,499
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5U54NS058572-02
|
9001
|
Biology Core
|
WELCH, ELLEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$48,877
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U54NS058572-02
|
9001
|
Biology Core
|
WELCH, ELLEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$436,378
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5U54AR050733-06
|
0001
|
Developing Clinical Outcomes for Gene Transfer
|
MENDELL, JERRY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$170,088
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5U54AR050733-06
|
0002
|
Preclinical Gene Therapy in a Large Animal Model of DMD
|
XIAO, XIAO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$4
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
5U54AR050733-06
|
0003
|
Muscle Stem Cell-based therapies for Cardiomyopathy
|
HUARD, JOHNNY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$184,281
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U54NS055958-02
|
0001
|
Dystrophin Restoration
|
MENDELL, JERRY
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$341,924
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U54NS055958-02
|
0002
|
CT GalNAc Transferase Gene Theraphy For DMD
|
MARTIN, PAUL
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$341,924
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U54NS055958-02
|
9002
|
Models Core
|
CHICOINE, LOUIS
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$341,927
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U54NS055958-02
|
9003
|
Immunology Core
|
WALKER, CHRISTOPHER
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$341,927
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
5U54NS055958-02
|
9004
|
Histopathology Core
|
SAHENK, ZARIFE
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$341,928
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
1U01NS058451-01A1
|
0001
|
NF-kB Inhibition Therapy for Duchenne Muscular Dystrophy
|
GUTTRIDGE, DENIS
|
OHIO STATE UNIVERSITY
|
OH
|
$680,381
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAMS
|
1U24NS059696-01A1
|
0001
|
National Center for Canine Models of Duchenne Muscular Dystrophy (NCDMD)
|
KORNEGAY, JOE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$300,000
|
|
Duchenne/ Becker Muscular Dystrophy
|
NINDS
|
1U24NS059696-01A1
|
0001
|
National Center for Canine Models of Duchenne Muscular Dystrophy (NCDMD)
|
KORNEGAY, JOE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$691,633
|
|
Duchenne/ Becker Muscular Dystrophy
|
NICHD
|
5U54HD053177-04
|
0001
|
Genetic Modifiers
|
CHEN, JOSEPHINE%
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$448,749
|
|
Duchenne/ Becker Muscular Dystrophy
|
NICHD
|
5U54HD053177-04
|
0002
|
Cell Damage and Remodeling
|
CHEN, YI-WEN%
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$223,375
|
|
Duchenne/ Becker Muscular Dystrophy
|
NICHD
|
5U54HD053177-04
|
0003
|
Satellite Cell Biology
|
PARTRIDGE, TERENCE%
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$448,751
|
|
Duchenne/ Becker Muscular Dystrophy
|
NICHD
|
5U54HD053177-04
|
9001
|
Human Clinical Core
|
ESCOLAR, DIANA%
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$223,375
|
|
Duchenne/ Becker Muscular Dystrophy
|
NCRR
|
5M01RR020359-04
|
7274
|
CNMC0601: A RANDOMIZED STUDY OF DAILY VS HIGH-DOSE WEEKLY PREDNISONE IN DUCHEN
|
ESCOLAR, DIANA
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$21,220
|
|
Duchenne/ Becker Muscular Dystrophy
|
NCRR
|
5M01RR020359-04
|
7301
|
CNMC0705: A DOUBLE-BLINDED RANDOMIZED PLACEBO CONTROLLED STUDY OF DAILY
|
ESCOLAR, DIANA
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$58,186
|
|
Duchenne/ Becker Muscular Dystrophy
|
NCRR
|
5M01RR000188-44
|
7777
|
CLINICAL TRIAL: DAILY VS WEEKLY PREDNISONE THERAPY IN DUCHENNE MUSCULAR DYSTROPH
|
LOTZE, TIMOTHY
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$892
|
|
Duchenne/ Becker Muscular Dystrophy
|
NCRR
|
5M01RR023940-02
|
8463
|
CLINICAL TRIAL: GENTAMICIN IN DUCHENNE MD
|
BAROHN, RICHARD
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$24,932
|
|
Duchenne/ Becker Muscular Dystrophy
|
NCRR
|
5M01RR000064-44
|
8610
|
STUDY OF INHERITED NEUROLOGICAL DISEASES
|
FLANIGAN, KEVIN
|
UNIVERSITY OF UTAH
|
UT
|
$1,289
|
|
Duchenne/ Becker Muscular Dystrophy
|
NCRR
|
5M01RR000064-44
|
8618
|
CLINICAL TRIAL: BECKER FACIOSCAPULOHUMERAL AND LIMB-GIRDLE MUSCULAR DYSTROPHY
|
FLANIGAN, KEVIN
|
UNIVERSITY OF UTAH
|
UT
|
$6,017
|
|
Duchenne/ Becker Muscular Dystrophy
|
NCRR
|
5M01RR000064-44
|
8627
|
CLINICAL TRIAL: NONSENSE-MUTATION-MEDIATED DUCHENNE MUSCULAR DYSTROPHY
|
FLANIGAN, KEVIN
|
UNIVERSITY OF UTAH
|
UT
|
$23,124
|
|
Duchenne/ Becker Muscular Dystrophy
|
NCRR
|
5M01RR000034-48
|
8738
|
CLINICAL TRIAL: SIX-MONTH (26 WEEKS) CLINICAL TRIAL OF GENTAMICIN IN DUCHENNE MD
|
MENDELL, JERRY
|
OHIO STATE UNIVERSITY
|
OH
|
$1,733
|
|
Duchenne/ Becker Muscular Dystrophy
|
NIAAA
|
1Z01AA000110-11
|
|
Metabolic Control Analysis
|
VEECH, RICHARD
|
NIH
|
|
$546,187
|
|
Duchenne/ Becker Muscular Dystrophy
|
NHLBI
|
1Z01HL005906-01
|
|
Electron Microscopy Core
|
LO, CECILIA
|
NIH
|
|
$313,247
|
